Peter Warn is Senior Vice President of Anti-infective Discovery at Evotec, where he leads antimicrobial discovery programmes and has scientific oversight of external client contracts.
Peter was a founder and Chief Scientific Officer of Euprotec before the company was acquired by Evotec.
Previously he was a senior lecturer at the University of Manchester, running a research group investigating the pathogenesis and treatment of severe infections. He has also lectured within Molecular Parasitology at the University of Oxford and, was a clinical scientist in Public Health England.
Peter has published 70 papers and over 400 conference abstracts. He has been awarded multiple research grants including by The Wellcome Trust, Medical Research Council, the Biotechnology and biological Sciences Research Council, the National Institutes of Health, and National Institute of Allergy and Infectious Diseases.
Peter holds a PhD in medical sciences from the University of Manchester.